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phospholipid vesicles was in fact higher when the peptide
was in the monomeric state rather than in the tetrameric
one.
Despite the dramatic effects of melittin on the permea-
bility of phospholipid vesicles to water and to water
solutes, the bilayer structure was preserved, as evidenced
by Pr(III) permeation experiments followed by 'H-NMR
and by low-angle x-ray and neutron diffraction analyses.
Although the lamellar pattern was not grossly perturbed,
melittin could be shown, by comparing the neutron scat-
tering profiles on absolute scale, to be present both at the
center of the bilayers and in the aqueous region separating
them, the peptide spanning therefore at least half of each
bilayer (Fig. 3). The increase of permeability to water
solutes caused by melittin was reflected, in H20/D20
exchange experiments, by a deeper penetration of water
into the lipid region of the bilayers (up to 4 A from the
center, at 95% relative humidity). Below Tm, the diffrac-
tion pattern seemed to be consistent with a lamellar array
of bilayers, together with an in-plane ordering of melittin-
phospholipid complexes. The presence of water appeared
in all cases to be essential for the incorporation of melittin
in the bilayer.
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The formation of an amphipathic helix, with segregation
of hydrophobic and hydrophilic residues on opposite sides
of the helix, is one mechanism by which proteins are
believed to interact with phospholipid bilayers (1). Gluca-
gon, a 29-amino acid polypeptide hormone, contains two
segments of amphipathic helix in its crystal structure (2).
It is capable of forming stable complexes with a number of
synthetic phospholipids including diheptanoyl (3); dica-
pryl;' dilauroyl (4); dimyristoyl (5); and dipalmitoyl (5)
phosphatidylcholine, as well as sphingomyelins (6),2 dimy-
ristoyl phosphatidylglycerol;3 and dipalmitoyl phosphati-
dylserine;3 but not with dimyristoyl phosphatidylethano-
lamine3 or diacyl phosphatidylcholines in the presence of
more than 20% cholesterol (6). Glucagon has also been
shown to interact with the detergent lysolecithin (3, 7).
RESULTS AND DISCUSSION
The interaction of glucagon with dimyristoyl phosphati-
dylcholine (DMPC) occurs rapidly around the phase tran-
sition temperature of the phospholipid (4) and leads to the
formation of a discoidal particle of 1.4 x 106 mol wt, 250
x 70 A (8). In this complex the glucagon has an increased
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helical content (9) and is believed to be located, at least in
part, around the rim of this disk. There are 55 mol of
DMPC/mol glucagon in the particle. The interaction of
glucagon with DMPC results in a marked broadening of
its phase transition and a shift in its temperature from
23.80 to 26.10C. There is also an additional small transi-
tion at 230 in presence of glucagon whose enthalpy is
one-quarter that for the 26.10C transition (10). The total
enthalpy change for the transition is reduced by glucagon
from 4.8 to 3.2 kcal/mol DMPC. This reduction may be
caused by the perturbation of the gel-state lipid in the
presence of the hormone as has been observed by Raman
spectroscopy (1 1). As a result of the change in the phase
transition behavior caused by glucagon there is a much
larger apparent heat capacity of the pure DMPC between
230 and 250C, where it is completely converted from solid
to liquid phase, than is the case for the glucagon-DMPC
complex which undergoes only a relatively small change in
phase in this temperature span (10). Thus there is a large
apparent ACp of reaction leading to a marked temperature
dependence of the isothermal enthalpy of reaction.
Expressed per mole of glucagon, the reaction enthalpy
changes from endothermic (+ 80 kcal/mol) at 230C to a
highly exothermic (-150 kcal/mol) at 250C. In the case
of glucagon the major contribution to the isothermal
enthalpy of reaction is found to be the glucagon-induced
phase change in the lipid (10). An analogous situation
should occur for any substance that causes a change in the
phase transition properties of a phospholipid.
The nature of the interaction between glucagon and
phospholipids is similiar to that between serum apolipopro-
teins and DMPC. In both cases discoidal particles contain-
ing a single phospholipid bilayer are formed (12-14) with
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similar phase transition properties (15, 16) and large
exothermic heats of reaction per mole of protein at 250C
(17, 18). It has also been recently reported that the
enthalpy of reaction of apolipoprotein A-1I with DMPC is
markedly temperature dependent, with the enthalpy
change becoming positive below the phase transition of the
phospholipid (19). In the case of the serum apolipopro-
teins, each protein molecule contains several segments of
amphipathic helix which may interact differently with
phospholipids, leading to the formation of a variety of final
products (20). However, with the small peptide glucagon
the lipoprotein particle appears to be quite uniform (8).
The main difference between glucagon and the serum
apolipoproteins in their interaction with DMPC is that in
the case of glucagon the complex dissociates at tempera-
tures above the phase transition region (5) while the serum
lipoprotein remains stable. In this regard glucagon is
similiar to a synthetic 20-residue model peptide (21). This
peptide as well as glucagon and the serum apolipoproteins
have increased helical content in the presence of phosphol-
ipid. However, only in the cases of glucagon and the model
synthetic peptide is the structure of the peptide in the
absence of lipid almost completely devoid of helix content.
The larger negative free energy contribution resulting
from the denaturation of small peptides upon dissociating
from a lipid bilayer may be the driving force leading to
their instability at higher temperatures. The maximal
thermodynamic stability of these small peptide-lipid
complexes occurs in the region of the phase transition of
the phospholipid where boundaries between lipid phases
may accommodate the peptide. At lower temperatures
these complexes have kinetic (22) but not thermodynamic
(6) stability.
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